
LUMA Vision, formerly OneProjects and founded in 2017 by Fionn Lahart and Christoph Hennersperger, is a venture-backed medical device company based in Dublin and Munich. They are developing VERAFEYE, an end-to-end platform technology focused on cardiac imaging to deliver data at the point of therapy. LUMA Vision operates at the intersection of hardware, software, and machine learning, creating advances in health-tech for physicians globally. The company aims to enable cardiologists to save lives through exceptional decision-making accuracy by providing an absolute and evidence-based understanding of patient wellbeing.

LUMA Vision, formerly OneProjects and founded in 2017 by Fionn Lahart and Christoph Hennersperger, is a venture-backed medical device company based in Dublin and Munich. They are developing VERAFEYE, an end-to-end platform technology focused on cardiac imaging to deliver data at the point of therapy. LUMA Vision operates at the intersection of hardware, software, and machine learning, creating advances in health-tech for physicians globally. The company aims to enable cardiologists to save lives through exceptional decision-making accuracy by providing an absolute and evidence-based understanding of patient wellbeing.
Founded: 2017
Headquarters: Dublin, Ireland (office in Munich, Germany)
Product: VERAFEYE — catheter-based 4D cardiac imaging and navigation platform
Employees: 79
Total disclosed funding: USD 53,980,000
Cardiac imaging and interventional cardiac procedure navigation
2017
Medical device / Health-tech
USD 12,000,000
Participation from Atlantic Bridge and Enterprise Ireland
USD 8,000,000
Package described as $17M including an $8M Series A2 led by imec.xpand, with participation from the EIC Fund, LSP and Atlantic Bridge; grants totaling $9M reported as part of the package
“Institutional venture investors including LSP, Atlantic Bridge, imec.xpand, participation from the European Innovation Council (EIC) Fund and Enterprise Ireland”